Axonics Modulation Technologies Inc
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retent… Read more
Axonics Modulation Technologies Inc (AXNX) - Total Liabilities
Latest total liabilities as of September 2024: $109.68 Million USD
Based on the latest financial reports, Axonics Modulation Technologies Inc (AXNX) has total liabilities worth $109.68 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Axonics Modulation Technologies Inc - Total Liabilities Trend (2016–2023)
This chart illustrates how Axonics Modulation Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Axonics Modulation Technologies Inc Competitors by Total Liabilities
The table below lists competitors of Axonics Modulation Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
The Campbell's Company
SA:C1PB34
|
Brazil | R$11.22 Billion |
|
Reply SpA
PINK:RPYTF
|
USA | $1.11 Billion |
|
DLVEY
PINK:DLVEY
|
USA | $580.90 Million |
|
SkyWest Inc
NASDAQ:SKYW
|
USA | $4.64 Billion |
|
COPT Defense Properties
NYSE:CDP
|
USA | $3.11 Billion |
|
Beijing New Building Materials Public Ltd Co
SHE:000786
|
China | CN¥8.74 Billion |
|
Dairy Farm International Holdings Limited
PINK:DFILF
|
USA | $6.68 Billion |
Liability Composition Analysis (2016–2023)
This chart breaks down Axonics Modulation Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Axonics Modulation Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Axonics Modulation Technologies Inc (2016–2023)
The table below shows the annual total liabilities of Axonics Modulation Technologies Inc from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $82.36 Million | -7.68% |
| 2022-12-31 | $89.21 Million | +36.19% |
| 2021-12-31 | $65.51 Million | +19.46% |
| 2020-12-31 | $54.84 Million | +48.93% |
| 2019-12-31 | $36.82 Million | +28.60% |
| 2018-12-31 | $28.63 Million | -55.79% |
| 2017-12-31 | $64.77 Million | +37.40% |
| 2016-12-31 | $47.14 Million | -- |